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THE LUCRATIVE AND POPULARITY OF SELLING MEDICINE
ONLINE
The rapid growth of technology has transformed many brick-and-mortar businesses into online
businesses, and medicines are now being sold over the internet. Influenced by the notions
that online purchases are economical and do not require a prescription, the general public
are keen to purchase medicine online through websites, social media and mobile apps. Online
medicine purchase is presumed to be convenient and confidential, free from embarrassment
of sharing personal and sensitive health information to a healthcare professional. Public in
United States, Europe, Australia is generally aware that internet sales form part of the official
medicines distribution channels, often a valid prescription is required for controlled medicine.
However, unlicensed, substandard and falsified medicines with various dubious medical claims
are advertised and sold illegally in many rogue online pharmacies (Jack, 2016). These include
medications for weight loss, hair growth, and treatment of erectile dysfunction. Such medicines are
termed as substandard, spurious, falsely labeled, falsified and counterfeit medical products by the
World Health Organisation (WHO). Similarly, the European Commission defines such products
as falsified medicines or fake medicines that pass themselves off as real, authorized medicines
(European Commission, 2016). These medicines may contain substandard active ingredients,
which are low quality and/or an incorrect amount, either too high or too low, and have not
been properly evaluated by authorities in terms of quality, safety, and efficacy. It must be noted
that falsified medicines are often confused with counterfeit medicines. According to European
Commission, counterfeit medicines refers to medicines that do not comply with European Union
law on intellectual and industrial property rights, for example, unregisteredmedicines sourced from
parallel import (European Medicines Agency1). In this article, the illegal sales of both counterfeit
and falsified medicines (CFMs) are discussed.
In 2012, the WHO estimated the CFMs industry to be worth USD 431 billion a year, but
further estimates has not been reported in the recent years due to the fast growing, widespread
practice of this industry, making it impractical to estimate on a global scale (Garrett, 2012).
Authorities are finding it difficult to curb CFMs due to the lack of governance over the internet.
Furthermore, fragmented cybercrime legislation leads to large substantive and procedural lacunae
in law, rendering law enforcement efforts useless.
1European Medicines Agency Falsified medicines. Available from: http://www.ema.europa.eu/ema/index.jsp?curl$=$pages/
special_topics/general/general_content_000186.jsp. Accessed 21 March 2017.
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PLAGUING THE LACUNAE: CASE STUDIES
OF INDIA, CHINA AND AFRICAN
COUNTRIES
The crackdown on CFMs sale by authorities can only be effective
with the present of relevant legislation to empower the judiciary
to impose substantial sentences. Countries such as China, India
and African countries previously had either no specific or weak
law governing the control of CFMs. To address this problem,
new legislations have been drafted and combined with the
existing legislation. Strengthening of drug legislation is vital
as CFMs are found alongside genuine medicines in legitimate
distribution channels, making it impossible for consumers to
determine the authenticity of the medicines (Office of the
United States Trade Representative, 2016). In 2013, the China
Food and Drug Administration led an inter-agency operation
named “Two Strikes, Two Setups” targeting illegal manufacture
and sale of medicines, which successfully closed down 194
Chinese websites and reported 609 overseas websites to their
relevant countries for further enforcement actions (Alliance
for Safe Online Pharmacies, 2015). China, believed to be the
biggest producers of CFMs, is showing encouraging signs in
this issue with the amendment of Article 141 of the Criminal
Law in 2011. The amended penalties for manufacturing and
selling CFMs are punishable to a minimum imprisonment
of 10 years, in addition to a fine or forfeiture of property
(Congressional-Executive Commission on China, 2011). For
India, harsh sentences imposed in 2008 through the Drug and
Cosmetic Act 1940 amendments, result in a minimum 10 years
and/or a minimum fine of Indian Rupees (INR) 1 million (USD
15,000) or three times the value of the medicines confiscated.
However, the anti-counterfeiting and anti-falsifying provision
does not extend to the regulating of online pharmacies, due
to the lack of clarity in the Drugs and Cosmetics Act 1940
and the Drugs and Cosmetics Rules 1945 (Nagaraj et al., 2014).
In December 2015, the office of the Drugs Controller General
(India) issued a directive banning the sale of medicines over
the internet and taking action against online pharmacies such
as Zigy.com, Netmeds.com and mCHEMIST.com (Reddy, 2015).
However, in the absence of clear legislations and policies on
online pharmacies, the directive is under scrutiny due to the
differences in the interpretation of law, impeding the authorities’
efforts to curb CFMs sold in illegal online pharmacies.
In Africa, the East African countries such as Uganda and
Kenya are strengthening and enforcing laws against CFMs.
Uganda’s new Anti-Counterfeiting Goods Bill, passed in October
2015 aims to introduce punitive, deterrent and effective measures
for combating the production or marketing of counterfeit goods.
Prior to 2015, there were no law that prohibits or controls the
manufacturing and marketing of counterfeit and falsified goods.
Although the National Drug Policy and Authority Act 1993
provides some guidance on the sale and supply of substandard
medicine, the non-specificity of this act on CFMs is seen as
the failure of Uganda war against the offense. In addition, a
minimum jail term (7 years) was introduced in the new bill, a
penalty absents from the National Drug Policy and Authority
Act (Parliament Watch, 2015). In Kenya, efforts against CFMs
have been strengthened significantly over the past few years, with
the establishment of the Anti-Counterfeit Act in 2008 and the
passing of several amendments. The latest amendment in 2014
paved the way for the establishment of an Intellectual Property
Enforcement and Co-ordination Advisory Committee and the
power to compound offenses, reducing the hassle and resources
of prosecution and conviction through the judiciary.
Nevertheless, the efforts of these countries in strengthening
pertinent legislation are inadequate with the growing widespread
availability of CFMs over the internet. This global public health
threat extends beyond national borders and many countries
currently do not have specific laws that deal with the selling of
CFMs over the internet (Govtrack.us, 2008).
WEANING IMPACT OF INTERNATIONAL
COLLABORATIVE OPERATIONS
Because of extensive intermediaries’ and suppliers’ networks
across the globe, the sale of CFMs through illegal online
pharmacies is difficult for law-enforcement agencies to control.
Such organized crimes mostly operate using rogue domain name
registrars, electronic payment systems and international and local
delivery services. Standalone enforcement efforts by individual
countries have failed to cripple the networks, only temporarily
ceasing operations in these countries before they became fully re-
operational after a few days. Seeing the need for an integrated
enforcement operation, INTERPOL along with other agencies
launched Operation Pangea, a global cooperative operation
targeting the online sale of CFMs. During the operations,
the makers and distributors of CFMs are identified and these
medicines are removed from the supply chain (INTERPOL,
2016).
In 2016, Operation Pangea IX targets 3 main aspects of
illicit medicine trafficking through the Internet Service Providers
(ISPs), payment systems and electronic delivery services. The
operation also targets some main aspects that are exploited
by organized crime in trafficking medicines online: fraudulent
domain name registrars, electronic payment systems and
medicine delivery. The success in these operations (Table 1)
is also because of the involvement of private internet-related
agencies and agencies that handle online payments. These
agencies such as MasterCard, PayPal and VISA are crucial
to curtailing financial support (INTERPOL, 2016). However,
Operation Pangea is slowly showing signs of over-inflated impact
as it is an intrinsic limitation to check enormous quality of
shipments from all custom checkpoints regularly and effectively.
WAY FORWARD: RAISING
INTERNATIONAL COLLABORATION AND
CONSUMER AWARENESS
Due to the sheer size of organized crime networks, stand-alone
operations in individual countries might not be adequate to stop
the overall trend. Concerted inter-country and inter-regional
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TABLE 1 | Results of operation pangea I till IX (2008 till 2016) (INTERPOL, 2016).
OP/Year Countries
participated
Agencies
involved
Websites
suspended
Suspects arrested/
under investigation
Number of pills
seized (millions)
Value of seized product
(USD millions)
Postal packages
seized
OP IX/2016 103 193 4,932 393 12.2 53 170,340
OP VIII/2015 115 236 2,410 156 20.7 81 NA
OP VII/2014 113 198 11,800 434 9.6 32 NA
OP VI/2013 99 NA 13,700 213 10.1 36 41,000
OP V/2012 100 NA 18,000 80 3.75 10.5 6,700
OP IV/2011 81 NA 13,500 55 2.4 6.3 8,000
OP III/2010 44 NA 297 87 2 6.77 NA
OP II/2009 25 NA 153 59 NA NA NA
OP I/2008 10 NA NA NA NA NA NA
Mean 77 209 8,099 185 9 32 56,510
Median 99 198 8,366 122 10 32 24,500
OP, Operation Pangea; NA, Not available.
operations may well be the answer to this conundrum. The
Alliance for Safe Online Pharmacies EU (ASOP EU), formed in
2011, is a coalition dedicated to protecting patient safety online.
Currently ASOP EU has 31 members including Google, Pfizer
and EAASM, as well as 26 observers including eBay, PayPal,
Visa and Microsoft (Alliance for Safe Online Pharmacies EU,
2016). Regional partnerships such as ASOP EU and EAASM
are important to exert influence on the political and legislative
bodies to ensure new regulation and regular enforcement of
online surveillance. Similarly, these alliances could strengthen
collaboration among law-enforcement agencies on cybercrime
involving pharmaceuticals and strengthen the human resource
and capacity to tackle cybercrime.
As a follow-up to the successful piece of research “The
Counterfeiting Superhighway,” EAASM launched an innovative
“Counterfeiting the Counterfeiter” campaign in Germany in
2011 to increase public awareness about CFMs sold online and
direct patients to safe and legitimate sources of medicines at
the same time. In this project, several websites were designed
to attract unsuspecting regular users to login to order their
medications without having a prescription. Immediately, when
the users clicked the purchase button, they were directed
to an authorized online pharmacy website which gave an
educational message about the risk of illegal websites. An
average of 2,800 people browsed the disguised websites each
day and the projected sales volume (based on items intended
for purchase) was USD 13.2–38.6 million per year. This
study confirmed the hypothesis of the EAASM that illegal
online pharmacies have low start-up costs and exorbitant
returns (European Alliance for Access to Safe Medicines,
2012).
The Falsified Medicines Directive was introduced by the
European Commission in 2013. It entails a certification mark or
common logo that is compulsory for websites selling medicinal
products to display. The certification mark will enable patients
to differentiate authorized online medicine retailers. These
authorized online retailers must provide a link on their webpage
to the national pharmaceutical regulator’s website to ensure
potential customers can double-check the authenticity of the legal
status of the operator.
Emphasis must be given to raise consumer awareness about
the risks and dangers of buying medicines online. The Medicines
and Healthcare products Regulatory Agency (MHRA) confirmed
that 79% of the UK public who took part in a survey on
online medicine purchases were unaware of CFMs (Medicines
Healthcare Products Regulatory Agency, 2016). As a result, the
MHRA is creating public awareness about CFMs sold online via
a campaign webpage with practical tips on recognizing legitimate
online retailers of medicines and medical devices (Medicines
Healthcare Products Regulatory Agency, 2016). The Food and
Drug Administration (FDA) in the US has embarked on a
similar campaign “BeSafeRx: Know Your Online Pharmacy”
to disseminate information about how to identify an illegal
pharmacy website and cues to detect illegal websites (U.S. Food
Drug Administration, 2016). It must be noted that the public is
advised to log on to the regulatory authorities’ portals to check
for the details of the medicine approvals as well as licensing. A
country-by-country list of the websites to check the medicine
registration information is available at http://crash2.lshtm.ac.uk/
Regulatory.htm. Online medicine retailers should always adhere
to the provisions of existing laws because selling medicines in
cyberspace does not mean they are outside of the law. The public
is also advised to be vigilant when buying medicines online and
should always make checks before clicking to purchase.
CONCLUSION
To date, health authorities’ efforts in combating CFMs by
strengthening the anti-counterfeit and anti-falsifying legislations
should be lauded. However, immediate action needs to be taken
to fill in the legislative lacunae of the online sale of CFMs. In
addition, the international collaboration against the online sale
of CFMs should be continued by encouraging more countries
to participate. Nevertheless, the fight against CFMs should not
be limited to legislation, enforcement and global collaboration of
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government authorities per se. Instead, multipronged strategies,
including adoption of anti-falsifiying technology and raising the
awareness among all stakeholders, principally the general public
may be the turning point in winning the battle against this
unscrupulous business.
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